Is using the formula (current blood glucose (CBG)-100)/20 or 30 to determine the preprandial dose of Glulisine (insulin lispro) an evidence-based practice?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 31, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is the Formula (CBG-100)/20 or 30 Evidence-Based for Preprandial Glulisine Dosing?

No, this formula is not evidence-based and should not be used for preprandial insulin dosing. The formula you describe appears to be a correction dose calculation, not a comprehensive preprandial insulin dosing strategy, and it fundamentally misunderstands how mealtime insulin should be administered.

Why This Formula Is Problematic

It Ignores Carbohydrate Coverage

  • Preprandial insulin must account for two components: carbohydrate coverage AND correction of elevated glucose 1, 2.
  • Your formula only addresses correction of hyperglycemia and completely omits the carbohydrate-to-insulin ratio (CIR), which is the primary determinant of mealtime insulin dosing 1.
  • The American Diabetes Association recommends calculating preprandial doses using: (Total carbohydrates ÷ CIR) + (Current glucose - Target glucose) ÷ ISF 1.

The Correction Factor Is Arbitrary

  • The divisor of 20 or 30 in your formula appears to be an approximation of the insulin sensitivity factor (ISF), but this should be calculated systematically 1.
  • The evidence-based ISF calculation is 1500 ÷ Total Daily Dose (TDD) for regular insulin or 1700 ÷ TDD for rapid-acting analogs 1.
  • Using a fixed divisor of 20-30 ignores individual insulin sensitivity, which varies dramatically based on body weight, insulin resistance, physical activity, and time of day 1.

The Target of 100 mg/dL May Be Inappropriate

  • The American Diabetes Association recommends a preprandial glucose target of 90-150 mg/dL (5.0-8.3 mmol/L), not a fixed 100 mg/dL 1.
  • Using 100 mg/dL as the universal target will lead to excessive correction doses and increased hypoglycemia risk in patients whose target should be higher 1.

Evidence-Based Preprandial Glulisine Dosing

The Correct Approach: Two-Component Calculation

For patients who count carbohydrates:

  • Carbohydrate coverage dose = Total meal carbohydrates (grams) ÷ Carbohydrate-to-Insulin Ratio (CIR) 1, 2
  • Correction dose = (Current glucose - Target glucose) ÷ Insulin Sensitivity Factor (ISF) 1
  • Total preprandial dose = Carbohydrate coverage + Correction dose 1

For patients who do NOT count carbohydrates:

  • Start with a fixed dose of 4 units per meal, 0.1 units/kg per meal, or 10% of basal insulin dose 2.
  • Add correction insulin using a simplified sliding scale: 2 units for glucose >250 mg/dL, 4 units for glucose >350 mg/dL 1.
  • Titrate the fixed meal dose by 1-2 units or 10-15% every 3 days based on 2-hour postprandial glucose readings 1, 2.

Calculating Your Insulin Sensitivity Factor (ISF)

The evidence-based formula is:

  • ISF = 1500 ÷ Total Daily Dose (TDD) for regular insulin 1
  • ISF = 1700 ÷ TDD for rapid-acting analogs like glulisine 1

For example, if your TDD is 50 units, your ISF would be 1500÷50 = 30 mg/dL per unit (meaning 1 unit of insulin lowers glucose by approximately 30 mg/dL) 1.

Calculating Your Carbohydrate-to-Insulin Ratio (CIR)

The evidence-based formula is:

  • CIR = 500 ÷ Total Daily Dose (TDD) for regular insulin 1
  • CIR = 450 ÷ TDD for rapid-acting analogs like glulisine 1

For example, if your TDD is 50 units, your CIR would be 450÷50 = 9 grams of carbohydrate per unit of insulin 1.

Glulisine-Specific Considerations

Pharmacokinetic Advantages

  • Glulisine demonstrates peak insulin concentration approximately twice that of regular human insulin, reached in approximately half the time 3.
  • It provides immediate availability for absorption after subcutaneous injection due to its unique formulation without zinc 3.
  • Glulisine shows greater rate of glucose utilization completed earlier compared to regular human insulin 3.

Clinical Evidence for Glulisine

  • When administered immediately pre-meal, glulisine provides superior postprandial blood glucose control compared to regular human insulin injected 30 minutes pre-meal 4.
  • In obese patients with type 2 diabetes, glulisine was associated with significantly lower glucose levels during the first hour after a standard meal (p=0.0455) 5.
  • Glulisine can be administered safely and effectively both pre- and post-meal, providing flexibility in dosing 4.

Timing of Administration

  • Rapid-acting insulin analogs like glulisine should be injected 0-15 minutes before meals for optimal postprandial glucose control 6, 2.
  • The flexibility of glulisine allows for administration immediately before or even after meals when carbohydrate intake is uncertain 4, 3.

Common Pitfalls to Avoid

Never Use Correction Insulin Alone for Meals

  • Correction insulin treats hyperglycemia reactively after it occurs rather than preventing postprandial excursions 1.
  • Your formula essentially uses only correction insulin, which will lead to dangerous glucose fluctuations and inadequate postprandial control 1.

Avoid Insulin Stacking

  • Do not give correction doses within 3-5 hours of the previous rapid-acting insulin dose, as insulin from the previous dose may still be active 1.
  • Glulisine has a duration of action of approximately 4 hours 4, 3.

Recalculate Parameters Periodically

  • ISF and CIR should be recalculated every few weeks to months, not daily, as total daily insulin requirements change 1.
  • Recalculation is particularly important during illness, changes in physical activity, or significant weight changes 1.

Adjust Individual Components Separately

  • If correction doses consistently fail to bring glucose into target range, adjust the ISF, not the meal dose 1.
  • If glucose after meals is consistently out of target, change the insulin-to-carbohydrate ratio (ICR) 1.

Practical Implementation Algorithm

Step 1: Calculate your baseline parameters

  • Determine your Total Daily Dose (TDD) = sum of all basal + bolus insulin over 24 hours 1
  • Calculate ISF = 1500 ÷ TDD (or 1700 ÷ TDD for rapid-acting) 1
  • Calculate CIR = 500 ÷ TDD (or 450 ÷ TDD for rapid-acting) 1

Step 2: Calculate preprandial dose

  • Count meal carbohydrates in grams 1
  • Carbohydrate dose = Total carbs ÷ CIR 1
  • Correction dose = (Current glucose - Target glucose) ÷ ISF 1
  • Total dose = Carbohydrate dose + Correction dose 1

Step 3: Administer and monitor

  • Inject glulisine 0-15 minutes before eating 6, 2
  • Check 2-hour postprandial glucose to assess adequacy 1, 2

Step 4: Titrate based on patterns

  • If 2-hour postprandial glucose consistently >180 mg/dL, increase meal dose by 1-2 units or 10-15% 1, 2
  • If hypoglycemia occurs, reduce corresponding dose by 10-20% 1, 2
  • Reassess and adjust ISF/CIR every 3 days during active titration 1

References

1
Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2
Guideline

Mealtime Insulin Initiation and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

6
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Is it still okay to administer the prescribed Humalog (insulin lispro) dose to an elderly patient with insulin-dependent diabetes whose blood sugar level increased from 5.8 mmol/L to 7.6 mmol/L after consuming apple juice?
What should be added to the current regimen of 4-20 units of lispro (insulin lispro) to control hyperglycemia in a patient with a glucose level of 300?
What to do for a patient with persistent severe hyperglycemia 15 minutes after administering 22 units of lispro (insulin lispro)?
Does taking insulin lispro (Humalog) plus protamine combination 5 minutes before food have a lesser effect on blood glucose control compared to taking it 10 minutes before food in a patient with diabetes?
What are the available brands of insulin glulisine (rapid-acting insulin analog) in India?
Should a patient with schizophrenia, on a permanent treatment plan including low-dose risperidone and clonazepam, taper off Caplyta after symptoms resolved following a missed dose?
What is the recommended use of Nicorandil (nicorandil) for treating angina pectoris in patients who have not responded to other anti-anginal medications?
Can a patient with gallstone pancreatitis have a normal white blood cell (WBC) count?
What is the difference between Q-switched (Quality-switched) lasers and ND YAG (Neodymium-doped Yttrium Aluminum Garnet) lasers in dermatological procedures?
What are the treatment options for a patient with palmar hyperhidrosis?
What are the best management strategies for a patient with peripheral arterial disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question